跳至主要内容
临床试验/NCT00225966
NCT00225966终止不适用

Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control

MedtronicNeuro2 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2004年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
153
试验地点
2
主要终点
Incidence of adverse events requiring surgical intervention

研究概览

简要总结

The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed and dated informed consent
  • 16 years of age or greater
  • Willing and able to complete voiding diaries and questionnaires at various time points during the study
  • Located geographically near the physician, or willing and able to travel to the physician's site as necessary for all required visits
  • Failed or is not a candidate for more conservative treatment

排除标准

  • Severe or uncontrolled diabetes; or diabetes with peripheral nerve involvement
  • Pregnancy or planned pregnancy
  • Concomitant medical conditions which would limit the success of the procedure such as: pelvic pain with uncertain etiology, active degenerative disc disease, spinal cord injury less than six months old, bleeding complications, or a cerebrovascular accident (CVA) less than six months old.
  • Anatomical limitations that would prevent successful placement of an electrode
  • Neurological diseases such as multiple sclerosis, clinically significant peripheral neuropathy or complete spinal cord injury (e.g., paraplegia)
  • Subject characteristics indicating a poor understanding of the study or poor compliance with the study protocol (e.g. subjects with psychological and/or emotional problems, subjects unable to adequately operate equipment)
  • Subjects with knowledge of planned magnetic resonance imaging (MRI), diathermy, microwave, high output ultrasonics, ultrasound scanning, or radiofrequency (RF) energy
  • Mechanical obstruction such as benign prostatic hypertrophy, cancer, or urethral stricture
  • Symptomatic urinary tract infection (UTI). Upon completion of therapy for UTI, or if the subject is receiving prophylaxis for UTI, subjects can be considered for test stimulation or the full system implant (whichever is applicable) if symptom free for one month prior to the procedure.
  • Subjects with other implantable neurostimulators, pacemakers, or defibrillators
  • Primary stress incontinence or mixed incontinence where the stress component overrides the urge component
  • Active participation in another clinical study

结局指标

主要结局

Incidence of adverse events requiring surgical intervention

Incidence of lead migration

次要结局

  • Incidence of infection

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验